An estimated 50 million people live with the irritating symptoms of dry eye, including redness, blurry vision, and a scratchy ...

Patients with relapsed or refractory chronic lymphocytic leukemia (R/R CLL) had similar results when they continued on ibrutinib or stopped and started ibrutinib plus venetoclax based on minimal ...

Nanoscope's MCO-010 therapy offers potential vision restoration without genetic testing or surgery, highlighting its commitment to accessible, innovative treatments. The establishment of the VAC ...

With the standardization and commercialization completed at an unforeseen pace for 5G wireless networks, researchers, engineers, and executives from academia and industry have turned their attention ...

Your diet plays a bigger role in your vision than you think. These nutrient-rich foods can help keep your eyes healthy as you ...

Westin describes the project's goals and its call to action for providers, payers, and systems alike.

Person-centered therapy, also known as Rogerian therapy or client-based therapy, employs a non-authoritative approach that allows clients to take more of a lead in sessions such that, in the ...

Those dreams include helping people experiencing vision loss better navigate the world around them, either by owning his own ...

Ocugen has a valuable IP portfolio, which should give it funding options. OCGN’s cash runway remains the main risk. Check out what makes OCGN worth a Buy.

For decades, the dominant treatment approaches for substance use disorder have centered around identifying past deficits and unpacking trauma. SFT offers a compelling alternative.

Since the approval of the first-ever gene therapy for blindness, there has been a wave of biotechs developing gene therapy treatments with the potential to cure different forms of genetic vision loss.